Kuros Biosciences AG (0RHR.L)

CHF 20.55

(1.23%)

Operating Income Summary of Kuros Biosciences AG

  • Kuros Biosciences AG's latest annual operating income in 2023 was -13.19 Million CHF , up 33.77% from previous year.
  • Kuros Biosciences AG's latest quarterly operating income in 2024 Q2 was -673 Thousand CHF , down 0.0% from previous quarter.
  • Kuros Biosciences AG reported an annual operating income of -13.44 Million CHF in 2022, down -53.37% from previous year.
  • Kuros Biosciences AG reported an annual operating income of -8.76 Million CHF in 2021, up 24.93% from previous year.
  • Kuros Biosciences AG reported a quarterly operating income of -4.65 Million CHF for 2023 Q2, down -105.7% from previous quarter.
  • Kuros Biosciences AG reported a quarterly operating income of -2.26 Million CHF for 2023 Q1, up 70.63% from previous quarter.

Annual Operating Income Chart of Kuros Biosciences AG (2023 - 2004)

Historical Annual Operating Income of Kuros Biosciences AG (2023 - 2004)

Year Operating Income Operating Income Growth
2023 -13.19 Million CHF 33.77%
2022 -13.44 Million CHF -53.37%
2021 -8.76 Million CHF 24.93%
2020 -11.67 Million CHF -2.52%
2019 -11.39 Million CHF 17.01%
2018 -13.72 Million CHF 15.49%
2017 -16.24 Million CHF 23.91%
2016 -21.34 Million CHF -3363.91%
2015 654 Thousand CHF 103.45%
2014 -18.93 Million CHF 18.61%
2013 -23.26 Million CHF -72.4%
2012 -13.49 Million CHF 31.55%
2011 -19.71 Million CHF -410.2%
2010 -3.86 Million CHF 85.81%
2009 -27.23 Million CHF -14.05%
2008 -23.88 Million CHF -187.75%
2007 -8.3 Million CHF 76.35%
2006 -35.09 Million CHF -19.7%
2005 -29.31 Million CHF -21.26%
2004 -24.17 Million CHF 0.0%

Peer Operating Income Comparison of Kuros Biosciences AG

Name Operating Income Operating Income Difference